National and Kapodistrian University of Athens
Ανοσολογική διαφοροποίηση ανοσοενεργοποίησης και ανασοπαράλυσης στη σήψη
Abstract
dc:descriptionThe state of immune activation may guide targeted immunotherapy in sepsis. In a double-blind, double-dummy randomized clinical study, 240 patients with sepsis due to lung infection, bacteremia or acute cholangitis are subject to measurements of serum ferritin and HLA-DR/CD14. Patients with macrophage activation-like syndrome (MALS) or immunoparalysis are randomized to treatment with anakinra or recombinant interferon-gamma or placebo. 28-day mortality is the primary endpoint; sepsis immune classification is the secondary endpoint. Using ferritin >4,420 ng/ml and < 5,000 HLA-DR receptors/monocytes as biomarkers, patients are classified into MALS (20.0%), immunoparalysis (42.9%) and intermediate (37.1%). Mortality is 79.1%, 66.9% and 41.6% respectively. Survival after 7 days with SOFA score decrease is achieved in 42.9% of patients of the immunotherapy arm and 10.0% of the placebo arm (p: 0.042). Three independent immune classification strata are recognized in sepsis. MALS and immunoparalysis are proposed as stratification for personalized adjuvant immunotherapy.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Leventogiannis, Konstantinos
- Λεβεντογιάννης, Κωνσταντίνος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58647